Investors

Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.

[mfdb_widget type='stock-table' token='0e0852f6-6c46-4428-8d3f-b226bac0e37c' locale='en']

Nasdaq Stockholm

[mfdb_widget type='stock-table' token='0e0852f6-6c46-4428-8d3f-b226bac0e37c' locale='en']

Price

[mfdb_widget type='stock-table' token='0e0852f6-6c46-4428-8d3f-b226bac0e37c' locale='en']

Change

Latest investor news

August 27, 2026

Test

Investor

June 10, 2026

Sofia Heigis presented at Aktiespararna

Investor

May 15, 2026

Oncopeptalks: Q1 report

Investor

May 13, 2026

Redeye interviews Oncopeptides CEO Sofia Heigis

Investor

May 8, 2026

Launching: Oncopeptalks as a podcast

Investor

March 23, 2026

CEO Sofia Heigis presented at Redeye event Commercialization in Life Science

Investor

March 20, 2026

Sofia Heigis presented and interviewed at Stockholm Corporate Finance Life Science Days

Investor

March 11, 2026

CEO Sofia Heigis presents Oncopeptides at Aktiespararna

Investor

August 27, 2026

Oncopeptides publishes Q2 report 2026

August 27, 2026

Oncopeptides publicerar rapporten för det andra kvartalet 2026

August 20, 2026

Invitation to presentation of the Q2 report 2026

August 20, 2026

Inbjudan till presentation av rapporten för andra kvartalet 2026

[mfdb_widget type='archive' token='04f45f21-f751-4c5e-8b9c-76d3b822b01f' locale='en']

[mfdb_widget type='archive' token='a1db22e4-3807-4f8a-8662-20ec5d2590cf' locale='en']

[mfdb_widget type='calendar-v2' token='e3b3f3fe-0df5-4dbf-8c63-76d881d4904d' locale='en']

No upcoming events

Investor Relations Contact

David Augustsson, MSc

Director of IR and Communications

ir@oncopeptides.com

+46 762 29 38 68

Investors

Latest investor news

Investor Relations Contact

More investor information

The share

General Meeting

Financial Reports

Financial Calendar